Guangbo Zhang

Dr. Guangbo Zhang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2022 in Gut
Verified
Journal Article
Open access
PDF file
LLLigong Lu
Ligong Lu
ZZZhi-Ling Zhou
Zhi-Ling Zhou
XWXu-Yan Wang
Xu-Yan Wang
BLBo-Yuan Liu
Bo-Yuan Liu
JLJin-Ying Lu
Jin-Ying Lu
YCYun Chen
Yun Chen
Objective: Patients with increased PD-L1 + host cells in tumours are more potent to benefit from antiprogrammed death-1/programmed death ligand-1 (PD-L1) treatment, but the underlying mechanism is still unclear. We aim to elucidate the nature, regulation and functional relevance of PD-L1 + host cells in hepatocellular carcinoma (HCC). Design: A total of untreated 184 HCC patients was enrolled randomly. C57BL/6 mice are given injection of Hepa1-6 cells to form autologous hepatoma. ELISpot, flow cytometry and real-time PCR are applied to analyse the phenotypic characteristics of PD-L1 + cells isolated directly from HCC specimens paired with blood samples or generated from ex vivo and in vitro culture systems. Immunofluorescence and immunohistochemistry are performed to detect the presence of immune cells on paraffin-embedded and formalin-fixed samples. The underlying regulatory mechanisms of metabolic switching are assessed by both in vitro and in vivo studies. Results: We demonstrate that PD-L1 + host macrophages, which constructively represent the major cellular source of PD-L1 in HCC tumours, display an HLA-DR high CD86 high glycolytic phenotype, significantly produce antitumourigenic IL-12p70 and are polarised by intrinsic glycolytic metabolism. Mechanistically, a key glycolytic enzyme PKM2 triggered by hepatoma cell derived fibronectin 1, via a HIF-1α-dependent manner, concurrently controls the antitumourigenic properties and inflammation-mediated PD-L1 expression in glycolytic macrophages. Importantly, although increased PKM2 + glycolytic macrophages predict poor prognosis of patients, blocking PD-L1 on these cells eliminates PD-L1-dominant immunosuppression and liberates intrinsic antitumourigenic properties. Conclusions: Selectively modulating the ‘context’ of glycolytic macrophages in HCC tumours might restore their antitumourigenic properties and provide a precise strategy for anticancer therapy.

17 October 2016 in Immunological Investigations
Verified
Journal Article
Closed access
ZWZhenxin Wang
Zhenxin Wang
NYNi Yin
Ni Yin
ZZZixiang Zhang
Zixiang Zhang
YZYi Zhang
Yi Zhang
GZGuangbo Zhang
Guangbo Zhang
WCWeichang Chen
Weichang Chen
T-cell immunoglobulin and mucin-domain containing-3 (Tim-3) is an important immune regulatory molecule in cancer immune system. However, expression and function of Tim-3 in monocytes/macrophages in cancer progression mainly remain unclear. In this study, we analyzed Tim-3 levels in peripheral blood mononuclear cells (PBMCs) from 62 gastric cancer patients and 45 healthy controls using flow cytometry and then associated Tim-3 levels with clinical pathological data from patients. We found Tim-3 level was significantly upregulated in monocytes from gastric cancer patients compared with those from healthy controls, and that upregulated Tim-3 levels associated with depth of tumor invasion and tumor lymph node metastasis and advanced clinical stages of gastric cancer patients. Furthermore, tumor-bearing mouse experiments revealed that Tim-3 level on monocytes/macrophages associated with xenograft formation and growth. In addition, culture of monocytes from healthy controls with gastric cancer cell-conditioned medium upregulated Tim-3 expression, but IL-10, TNF-α, IFN-γ, or GM-CSF treatment or T-bet, Eomes, and T-bet/Eomes double gene knockout did not affect Tim-3 levels in blood monocytes/macrophages from human or mouse, respectively. Gal-9/Tim-3 signal was able to significantly stimulate monocyte to secrete IL-6, IL-8, and IL-10, but not IL-1β, IL-12p70, or TNF-α in presence of LPS. In conclusion, our study demonstrated that Tim-3 expressed by monocyte/macrophages might be an important mechanism in gastric cancer progression.

11 September 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
QZQiu-Hui Zeng
Qiu-Hui Zeng
YWYuan Wei
Yuan Wei
XLXiang-Ming Lao
Xiang-Ming Lao
DCDong-Ping Chen
Dong-Ping Chen
CHChun-Xiang Huang
Chun-Xiang Huang
DKDong-Ming Kuang
Dong-Ming Kuang
B cells have a previously unrecognized helper function in triggering pathogenic differentiation of inflammatory T H subsets.

4 April 2017 in Immunological Investigations
Verified
Journal Article
Closed access
YCYa Cao
Ya Cao
HHHaitao Huang
Haitao Huang
ZWZhenxin Wang
Zhenxin Wang
GZGuangbo Zhang
Guangbo Zhang
Aims: To investigate the clinical significance of tumor tissue-infiltrating chemokines expression in non-small cell lung cancer (NSCLC) microenvironment. Materials and methods: Fresh tissue samples were acquired from 50 patients with NSCLC after operation. Then, we quantified the total protein with the BCA Protein Assay Kit and tested 13 chemotactic factors in paired samples including tumor tissues, tumor adjacent tissues, and normal tissues with the CBA Kit. Results: We found that the chemokine CC subfamily of MCP-1, MIP-1α, MIP-1β, and MIP-3α and the chemokine CXC subfamily of IL-8, GROα, IP-10, and MIG expressions in tumor tissues were significantly higher than those in tumor-adjacent tissues and normal tissues. However, regulated upon activation normal T cell expressed and secreted (RANTES), human thymus activation regulated chemokine (TARC), chemokine (C-C motif) ligand 11 (CCL11), interferon-inducible T cell alpha chemoattractant (I-TAC), and ENA-78 expressions did not show significant difference. Analyzing the influence of chemokine expression level in tumor tissues on disease progression, we found the median progression-free survival (mPFS) of patients with GROαhigh was significantly lower than those with GROαlow; mPFS of patients with IP-10low was significantly lower than those with IP-10high; and mPFS of patients with MIGlow was significantly lower than those with MIGhigh. However, MCP-1, MIP-1α, MIP-1β, MIP-3α, and IL-8 had no significant value to elevate the mPFS of patients with NSCLC. Conclusion: In summary, tumor tissue-infiltrating CXC chemokines, GROαhigh, IP-10low, and MIGlow in the tumor microenvironment can be used as potential indicators for the progression of NSCLC.

3 January 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
HJHuang Jian
Huang Jian
SFShen Fangrong
Shen Fangrong
HHHuang Haitao
Huang Haitao
LCLing Chunhua
Ling Chunhua
GZGuangbo Zhang
Guangbo Zhang
Th1 high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC Th1high in tumor microenvironment is an indicator of poor prognosis for patients with NSCLC

22 January 2024 in Translational Oncology
Verified
Journal Article
Open access
DZDongze Zhang
Dongze Zhang
HHHaitao Huang
Haitao Huang
XGXin Gao
Xin Gao
GYGehua Yu
Gehua Yu
XZXueguang Zhang
Xueguang Zhang
GZGuangbo Zhang
Guangbo Zhang
Monocyte/macrophages constitute a significant population of tumor-infiltrating immune cells and play a crucial role in tumor growth, invasion, and metastasis. B7-H3, has immune regulatory functions, however, it is unclear whether B7-H3 expressed on monocyte/macrophages plays a significance role in tumor progression. We found B7-H3 was high-expressed on monocyte/macrophages in tumor microenvironment compared with adjacent tissues in lung cancer, and its expression level was positively correlated with the number of monocyte/macrophages. Furthermore, the expression of B7-H3 was related to clinical stage and lymph node metastasis. Moreover, miR-29a-3p negatively regulated B7-H3, and the expression of B7-H3 on THP-1-derived macrophages was regulated by secreting exosomes containing miR-29a-3p. In addition, knockdown of B7-H3 promoted macrophage apoptosis under hypoxia. Mechanistically, B7-H3 enhanced the antiapoptotic ability of macrophage by up-regulating HIF-1ɑ via activating NF-κB. Taken together, these results imply that B7-H3 as a therapeutic target could hold promise for enhancing anti-tumor immune responses in individuals diagnosed with lung cancer.